The sensitivity and specificity of the Bio-EnzaBead test for syphilis and the fluorescent treponemal antibody-absorption (FTA-ABS) 
Several investigators have examined the enzyme immunoassay procedure as a diagnostic treponemal test for syphilis (1, 3, 6 28, 1984) . The test is a modification of the enzyme-linked immunosorbent assay and uses ferrous metal beads as a solid-phase carrier for antigen prepared from Treponema pallidum (Nichols strain). The presence of treponemal antibody in a test serum sample is indicated by enzyme-substrate color intensity which may be read visually or spectrophotometrically and compared with a cutoff value established with control sera.
Previous evaluations of the syphilis Bio-EnzaBead test used visual estimations of color intensity measured on a scale of weakly positive (1+) through highly positive (4+) to determine the reactivity of specimens (4) . A color intensity of 1+ or greater was considered positive, while specimens with a definite color intensity of less than 1+ were retested. Retests read at 1+ or greater were reported positive, while those read at less than 1+ were reported negative. The test was reported unsatisfactory if the control well color intensity was equal to or greater than that of the test well. When the syphilis Bio-EnzaBead test was compared with the fluorescent treponemal antibody-absorption (FTA-ABS) test, the sensitivity (96.7%), specificity (96.1%), and overall reliability (96.3%) for 1,338 serum samples supported a recommendation to consider the Bio-EnzaBead test as an alternative to the FTA-ABS test (4 true-negative tests resulted in a reliability of 95.8%. Falsenegative Bio-EnzaBead tests (n = 10) occurred in late-latent syphilis (n = 9) and syphilis for which the stage could not be determined (n = 1). One false-positive Bio-EnzaBead test occurred, and the cause could not be determined. When Bio-EnzaBead was read visually, the reliability was 85.8%. False-negative tests occurred in primary syphilis (n = 3), neurosyphilis (n = 1), congenital syphilis (n = 2), late-latent syphilis (n = 24), and syphilis for which the stage could not be determined (n = 6). A summary of laboratory results of the nontreponemal and treponemal tests compared with patient history is presented in Table 1 .
The method for comparison of syphilis history and treponemal test results and our definitions of sensitivity, specificity, and reliability are shown in Table 2 . Our analysis of these data by use of this method is presented in Table 3 .
There was no statistical difference between the sensitivity and overall reliability of the FTA-ABS and Bio-EnzaBead tests (P > 0.3). The Bio-EnzaBead test was significantly more specific than the FTA-ABS test (P < 0.01). There was no significant difference between tests for any stage of syphilis (P > 0.2). When the Bio-EnzaBead test was read visually, the sensitivity and overall reliability of the test were significantly lower than those obtained with the spectrophotometer calibrated to a substrate blank (P < 0.01).
The reproducibility data are presented in Table 4 . Visual test readings corresponded exactly with expected readings for 67% of samples, while 98% of samples were read within one gradation of the expected result. The one reading which deviated by two gradations occurred when a 1 + serum sample was read as negative. Additionally, two serum samples with 1 + reactivity were read as + and would be reported nonreactive. The reliability of visual readings for the reproducibility test sera was 95%. No discrepancies occurred with spectrophotometric readings calibrated to an air blank for 100% reliability. When a substrate blank was used, the test reliability was 98%. The single discrepant serum sample had an R x D value 0.011 units above the cutoff.
DISCUSSION
The syphilis Bio-EnzaBead kit provides sufficient reagents to test 96 serum samples together with necessary controls. We used the accessory package, which includes flat-bottom microtiter plates and clear covers. Control and antigen beads are packaged 24 per vial, and beads are stable for 28 days after the package is opened. Our laboratory receives an average of 10 serum samples per day for treponemal antibody testing. This specimen volume corresponds to approx- Required support equipment for the test includes the magnetic transfer device, the model LBI-30 multichannel recording spectrophotometer, and a bead dispenser. Optional equipment includes a Hamilton digital diluter to facilitate the preparation of the initial serum dilution of 1:101. The Spirit 80 (Mannesmann Tully Corp.) printer was set up on a stand over the spectrophotometer so that only 45 cm by 50 cm of bench space was required. The paper printout was conveniently arranged to correspond to the well pattern of the microtiter plate for easy comparison of visual versus spectrophotometric readings. Plate position and absorbance value were printed for each well read. The automated readout and manual R x D calculations require only 10% of the time necessary to read and record the results of the FTA-ABS test.
The advantages of the syphilis Bio-EnzaBead test over the FTA-ABS test include speed of performance, brief serologist training time (3 to 5 days), elimination of expensive microscopy equipment, and elimination of fatigue and eye strain associated with microscopy. A further advantage of the syphilis Bio-EnzaBead test is elimination of the subjective evaluation of fluorescence intensity to determine the endpoint between reactive and nonreactive sera. This last advantage is lost when Bio-EnzaBead is read visually.
The specimens included in this study represented patients with all stages of syphilis. Sera were inactivated at 56°C for 30 min prior to performance of the VDRL and FTA-ABS Both treponemal tests demonstrated some lack of sensitivity with sera from patients with late-latent syphilis, but there was no statistical difference between the tests for diagnosis of any stage of syphilis. The syphilis BioEnzaBead test produced significantly fewer false-positive tests than did the FTA-ABS test. The overall reliability of the two treponemal tests was identical in this study when Bio-EnzaBead tests were read spectrophotometrically.
Our results indicate that visual readings are highly specific but lack the sensitivity and overall reliability required of a diagnostic treponemal test for syphilis. When substrate blanks were used for instrument calibration and tests were read spectrophotometrically, the sensitivity and overall reliability were equivalent to those of the FTA-ABS test, while the specificity was significantly greater.
The reproducibility of the syphilis Bio-EnzaBead test was determined by testing 60 coded serum samples prepared from six serum pools of known reactivity. Reproducibility was excellent overall, whether tests were read visually or spectrophotometrically with air or substrate blanks. Visual readings were poorest on sera from pool D, which gave 1+ reactivity. Of these 16 serum samples, 3 were read as equivocal or nonreactive because of an inability to visually detect color in the wells. No discrepancies occurred when the spectrophotometer was used with air blank calibration, and only one discrepancy occurred with substrate blank calibration. This latter discrepancy occurred when one sample from nonreactive pool F was read as reactive. No cause could be determined, and an insufficient quantity of serum was available to repeat the test.
We were particularly interested in the reproducibility of the nonreactive, weakly reactive, and highly reactive control sera within each plate and throughout the study. Thoughtful distribution of control sera recommended by the kit manufacturer demonstrated no evidence of systematic error, thereby ensuring that each run was in control. We did observe an increase in absorbance values when negative control beads were tested against highly reactive sera, but the mean of optical densities for these negative control beads (0.017) was well below the mean of optical densities for weakly reactive sera tested against antigen control beads (0.063). The reproducibility of R x D values for control sera was acceptable.
Serum from one pregnant female and two patients with lupus erythematosus gave false-positive results with the FTA-ABS test but not the syphilis Bio-EnzaBead test. Because of the higher specificity and equal sensitivity, the Bio-EnzaBead test is recommended as an alternative to the FTA-ABS test as a treponemal antibody test for the diagnosis of syphilis.
